Endoscopic multivisceral access through single incisions represents a significant leap in minimally invasive surgery, facilitating simultaneous intervention on multiple intra-abdominal organs while minimizing patient trauma. This review explores current techniques, evaluates clinical outcomes, and discusses the implications for practice, focusing on recent evidence and guideline-based recommendations. The article synthesizes prevailing clinical data, addresses pathophysiological concepts, delineates risk factors, examines diagnostic and therapeutic strategies, and assesses both the benefits and challenges of this evolving field in the context of modern surgical innovation.
Minimally invasive surgery has transformed operative management across numerous specialties, with single-incision laparoscopic surgery (SILS) emerging as a pivotal advancement. The concept of endoscopic multivisceral access through single incisions builds upon SILS by enabling concurrent evaluation and treatment of multiple abdominal organs via a solitary entry point, typically at the umbilicus. This approach is particularly compelling for complex and multifocal pathologies, offering reduced postoperative pain, decreased wound morbidity, shorter hospital stays, and improved cosmesis compared to multi-port techniques. As surgical technology and operator expertise advance, the clinical indications for this methodology are expanding, warranting a comprehensive review of its applications, safety profile, and future prospects.
The burden of diseases amenable to multivisceral intervention—such as synchronous colorectal and gynecological malignancies, multifocal inflammatory processes, or combined cholecystectomy and appendectomy—remains substantial worldwide. Traditional multi-port laparoscopy, while effective, is associated with incremental risks of infection, hernia, and adhesions with each additional incision. The drive to minimize these risks has catalyzed the development of single-incision approaches. Population-based studies suggest that the prevalence of conditions suitable for single-incision multivisceral surgery is rising, partially due to earlier detection and the aging population, underscoring the clinical and economic importance of optimizing access techniques.
Multivisceral pathology frequently involves interconnected inflammatory, neoplastic, or infectious processes across multiple abdominal organs. The rationale for single-incision access draws from the anatomical proximity of viscera and the convergence of disease processes, particularly within the pelvis and upper abdomen. By utilizing a central access point, surgeons can exploit natural tissue planes, reduce peritoneal trauma, and maintain physiological integrity. Mechanistically, limiting entry sites diminishes the cumulative insult to the abdominal wall and peritoneum, theoretically reducing the systemic inflammatory response and subsequent postoperative complications.
Patient selection is paramount in single-incision multivisceral surgery. Risk factors influencing outcomes include obesity (which may impede visualization and instrument maneuverability), previous abdominal surgeries with resultant adhesions, complex or extensive disease requiring wide resection, and comorbidities such as cardiopulmonary instability. Operator experience, instrument ergonomics, and case complexity also play critical roles in procedural success and complication rates.
Indications for endoscopic multivisceral access via single incision are diverse. Synchronous colorectal and gynecological surgeries, combined hepatobiliary-pancreatic procedures, and concurrent resection of multifocal tumors exemplify clinical scenarios wherein this approach is advantageous. Patients typically present with multifocal abdominal symptoms, such as pain, mass effect, or organ-specific dysfunction, necessitating comprehensive evaluation and intervention. The single-incision technique may be particularly beneficial in younger or cosmetic-conscious populations, or when minimizing surgical footprint is clinically advantageous.
Preoperative diagnosis hinges on high-resolution cross-sectional imaging (CT, MRI) and endoscopic assessment to delineate the extent of multivisceral involvement. Advanced imaging facilitates operative planning, allowing the surgical team to anticipate technical challenges, plan access trajectories, and coordinate multidisciplinary care. Intraoperatively, the single-incision approach enables direct visualization and palpation of multiple organs, potentially improving diagnostic yield for occult or complex pathologies.
The operative technique involves the placement of a specialized multi-lumen port, typically at the umbilicus, and the use of articulating instruments and flexible endoscopes to access and manipulate multiple organs. Procedures may include combined resections (e.g., colorectal and ovarian), cholecystectomy with appendectomy, or lysis of adhesions in multifocal disease. Meticulous surgical planning is essential to avoid instrument crowding and ensure adequate exposure. Postoperative care focuses on early mobilization, pain control, and prompt recognition of complications, with most patients benefiting from expedited recovery and reduced hospital stays.
Technological innovations have propelled the field forward. Articulating and roticulating instruments, advanced energy devices, and high-definition 3D visualization systems have improved maneuverability and precision. Robotic single-port platforms are under investigation, offering enhanced dexterity, tremor filtration, and improved ergonomics. Several recent trials, including randomized controlled studies, report equivalence or superiority of single-incision approaches in select multivisceral operations, with ongoing research into their applicability for increasingly complex cases.
Societal guidelines from surgical and gastroenterological associations endorse single-incision approaches for select indications, emphasizing the importance of appropriate patient selection, operator experience, and institutional resources. The European Association for Endoscopic Surgery and the Society of American Gastrointestinal and Endoscopic Surgeons recommend single-incision multivisceral surgery for patients with localized disease, minimal obesity, and low predicted complexity, while advocating for conventional multi-port or open approaches in cases of extensive adhesions or advanced malignancy. Ongoing accumulation of high-level evidence will further refine these guidelines.
Endoscopic multivisceral access through single incisions represents a paradigm shift in minimally invasive surgery, offering tangible benefits in terms of reduced morbidity, enhanced cosmesis, and potentially improved clinical outcomes. While challenges remain—including technical complexity, patient selection, and cost—ongoing innovation and accumulating evidence are likely to expand indications and improve safety. Adherence to guideline-based practice and rigorous training are essential to optimize results. As technology and surgical expertise continue to evolve, single-incision multivisceral access will play an increasingly prominent role in the landscape of advanced minimally invasive surgery.
1.
Tumor characteristics found to differ for melanomas in children, teens and young adults
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
5.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
1.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
2.
Screening for Early Therapy-Related Cancer Susceptibility
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Importance of Cancer Screening and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation